Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

366 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Multidrug resistance in cancer: role of ATP-dependent transporters.
Gottesman MM, Fojo T, Bates SE. Gottesman MM, et al. Nat Rev Cancer. 2002 Jan;2(1):48-58. doi: 10.1038/nrc706. Nat Rev Cancer. 2002. PMID: 11902585 Review.
Drug development: portals of discovery.
Bates SE, Amiri-Kordestani L, Giaccone G. Bates SE, et al. Clin Cancer Res. 2012 Jan 1;18(1):23-32. doi: 10.1158/1078-0432.CCR-11-1001. Clin Cancer Res. 2012. PMID: 22215903
Epigenetic modifiers: basic understanding and clinical development.
Piekarz RL, Bates SE. Piekarz RL, et al. Clin Cancer Res. 2009 Jun 15;15(12):3918-26. doi: 10.1158/1078-0432.CCR-08-2788. Epub 2009 Jun 9. Clin Cancer Res. 2009. PMID: 19509169 Free PMC article.
A phase I study of the P-glycoprotein antagonist tariquidar in combination with vinorelbine.
Abraham J, Edgerly M, Wilson R, Chen C, Rutt A, Bakke S, Robey R, Dwyer A, Goldspiel B, Balis F, Van Tellingen O, Bates SE, Fojo T. Abraham J, et al. Clin Cancer Res. 2009 May 15;15(10):3574-82. doi: 10.1158/1078-0432.CCR-08-0938. Epub 2009 May 5. Clin Cancer Res. 2009. PMID: 19417029 Free PMC article. Clinical Trial.
Population pharmacokinetics of romidepsin in patients with cutaneous T-cell lymphoma and relapsed peripheral T-cell lymphoma.
Woo S, Gardner ER, Chen X, Ockers SB, Baum CE, Sissung TM, Price DK, Frye R, Piekarz RL, Bates SE, Figg WD. Woo S, et al. Clin Cancer Res. 2009 Feb 15;15(4):1496-503. doi: 10.1158/1078-0432.CCR-08-1215. Clin Cancer Res. 2009. PMID: 19228751 Free PMC article. Clinical Trial.
Advancing Clinical Trials to Streamline Drug Development.
Bates SE, Berry DA, Balasubramaniam S, Bailey S, LoRusso PM, Rubin EH. Bates SE, et al. Clin Cancer Res. 2015 Oct 15;21(20):4527-35. doi: 10.1158/1078-0432.CCR-15-0039. Clin Cancer Res. 2015. PMID: 26473188 Free PMC article.
CCR 20th Anniversary Commentary: Expanding the Epigenetic Therapeutic Portfolio.
Bates SE, Robey RW, Piekarz RL. Bates SE, et al. Clin Cancer Res. 2015 May 15;21(10):2195-7. doi: 10.1158/1078-0432.CCR-14-2555. Clin Cancer Res. 2015. PMID: 25979924
A phase i study of DMS612, a novel bifunctional alkylating agent.
Appleman LJ, Balasubramaniam S, Parise RA, Bryla C, Redon CE, Nakamura AJ, Bonner WM, Wright JJ, Piekarz R, Kohler DR, Jiang Y, Belani CP, Eiseman J, Chu E, Beumer JH, Bates SE. Appleman LJ, et al. Clin Cancer Res. 2015 Feb 15;21(4):721-9. doi: 10.1158/1078-0432.CCR-14-1333. Epub 2014 Dec 2. Clin Cancer Res. 2015. PMID: 25467180 Free PMC article. Clinical Trial.
Changing the paradigms of treatment in peripheral T-cell lymphoma: from biology to clinical practice.
O'Connor OA, Bhagat G, Ganapathi K, Pedersen MB, D'Amore F, Radeski D, Bates SE. O'Connor OA, et al. Clin Cancer Res. 2014 Oct 15;20(20):5240-54. doi: 10.1158/1078-0432.CCR-14-2020. Clin Cancer Res. 2014. PMID: 25320373 Review.
Effects of Anticancer Drugs on Chromosome Instability and New Clinical Implications for Tumor-Suppressing Therapies.
Lee HS, Lee NC, Kouprina N, Kim JH, Kagansky A, Bates S, Trepel JB, Pommier Y, Sackett D, Larionov V. Lee HS, et al. Cancer Res. 2016 Feb 15;76(4):902-11. doi: 10.1158/0008-5472.CAN-15-1617. Epub 2016 Feb 2. Cancer Res. 2016. PMID: 26837770 Free PMC article.
366 results
Jump to page
Feedback